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Abstract: The current treatment options for soft tissue injuries remain suboptimal and often 
result in delayed/incomplete recovery of damaged muscle. The current study aimed to 
evaluate the effects of oral Prosopis glandulosa treatment on inflammation and regeneration 
in skeletal muscle after contusion injury, in comparison to a conventional treatment.  
The gastrocnemius muscle of rats was subjected to mass-drop injury and muscle samples 
collected after 1-, 3 h, 1- and 7 days post-injury. Rats were treated with P. glandulosa  
(100 mg/kg/day) either for 8 weeks prior to injury (up until day 7 post-injury), only  
post-injury, or with topically applied diclofenac post-injury (0.57 mg/kg). Neutrophil 
(His48-positive) and macrophage (F4/80-positive) infiltration was assessed by means of 
immunohistochemistry. Indicators of muscle satellite cell proliferation (ADAM12) and 
regeneration (desmin) were used to evaluate muscle repair. Chronic P. glandulosa and 
diclofenac treatment (p < 0.0001) was associated with suppression of the neutrophil response 
to contusion injury, however only chronic P. glandulosa treatment facilitated more effective 
muscle recovery (increased ADAM12 (p < 0.05) and desmin (p < 0.001) expression), while 
diclofenac treatment had inhibitory effects on repair, despite effective inhibition of 
neutrophil response. Data indicates that P. glandulosa treatment results in more effective 
muscle repair after contusion. 
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1. Introduction 
Soft tissue injuries are very common, accounting for between 35% and 55% of all sporting  
injuries [1]. Soft tissue injuries can result in significant pain, swelling and bruising, culminating in 
delayed and impaired functionality of the affected muscle [2]. The pathophysiology of muscle injuries 
is a complex process, progressing through a sequence of overlapping phases, which include 
degeneration, inflammation, regeneration and the formation of fibrotic scar tissue [3–6]. Injuries to 
skeletal muscle not only damages the muscle cells itself, but may also lead to capillary rupture, 
infiltrative bleeding, inflammation, oxidative stress and fibrosis, depending on the extent of the injury. 
Inflammation stands central to these processes, with inflammatory cytokines largely responsible for 
modulating the cellular environment, thereby largely controlling the progress of other repair processes. 
Therefore, inflammation is the most likely target to consider when developing treatments to facilitate 
faster recovery. 
In recent years, researchers have focused on manipulation of inflammation to accelerate muscle 
regeneration, for example, by targeting immune cells activated during the inflammatory phase [7,8]. 
Neutrophils and macrophages enter the site of injury in response to chemotactic signals and phagocytize 
the local debris [5,9,10]. Neutrophils, along with macrophages and satellite cells, release oxygen free 
radicals, resulting in oxidative stress and direct damage to surrounding tissue unaffected by the primary 
injury, which results in secondary muscle damage. However, even though early stage phenotypes of 
macrophages partially contributes to the sustainability of the inflammatory response and thus also 
secondary damage, these cells also secrete various growth factors that directly contribute to tissue repair 
and regeneration [5,11]. Additionally, both neutrophils and macrophages stimulate the release of 
cytokines (IL-1, IL-6, IL-8) and other chemotactic factors by T-cells, which inevitably results in the 
recruitment of satellite cells, with thus a greater capacity for muscle regeneration [5,12,13]. It is  
therefore clear that the inflammatory response, even though a contributor to secondary damage, is crucial 
to the repair of skeletal muscle after injury. Thus in the event of this total process being severely blunted 
for a prolonged period of time, such as through non-steroidal anti-inflammatory drug (NSAID) 
treatment, the potential clinical outcome may be suboptimal, resulting in delayed and/or incomplete 
tissue healing, as well as excessive scar formation, which increases the risk for recurrence of injury. 
There is evidence that suggests that the prolonged inhibition of the cyclooxygenase-2 pathway (more 
than 7 days continually) with prostaglandin inhibitors (NSAIDs) compromises muscle repair [4,14,15]. 
In addition to the use of NSAID’s, there are various other muscle injury treatment options, such as the 
RICE approach (rest, ice, compression and elevation) [4,16–18], therapeutic ultrasound [19,20], 
hyperbaric oxygen therapy [21] and the use of growth factors [22]. However, these therapies remain 
suboptimal, as in many instances it either does not translate into increased myotube formation, therefore 
does not enhance muscle healing [19,20] and may be associated with severe risks and side effects [23]. 
The potential for targeting the inflammatory response using natural products was recently  
illustrated in a similar model to the one used in our study, when accelerated skeletal muscle recovery 
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(after treatment with a grape-seed derived polyphenol) was associated with a suppression of the 
neutrophil response to contusion injury, less secondary damage and earlier macrophage phenotype 
switch which resolved inflammation faster [7,24]. We therefore hypothesized that treatment with the 
pods of Prosopis glandulosa (Torr.) (Fabaceae) would blunt neutrophil infiltration into the site of injury, 
thereby alleviating the inflammatory response and consequently enhance muscle regeneration. Mesquite, 
which is a common name for several species of the leguminous plants of the Prosopis genus, have been 
found to contain numerous phytochemicals eliciting various effects, such as anti-inflammatory  
effects [25]. Very few studies have been conducted on the P. glandulosa plant itself and no literature 
could be found regarding its potential clinical benefits, except those from our own laboratory [26,27], 
which were performed in a different context (diabetes and cardiovascular health). However, since 
diabetes and cardiovascular health both have known inflammatory components, it is likely that this 
product could also have therapeutic application in the context of inflammatory muscle injury.  
Particular strengths of this study are the inclusion of a recognized NSAID commonly used in the 
treatment of muscle injury and inflammation–diclofenac–as comparative control, as well as the fact that 
the treatment was tested for both its capacity as a preventative chronic supplement and for acute 
therapeutic application. 
2. Experimental Section 
2.1. Experimental Animals 
Age- and weight-matched adult, male, Wistar rats were used. All animals were housed at the 
Stellenbosch University Central Research Facility, Tygerberg, in temperature controlled rooms  
(22–24 °C) and kept on a 12-h light/dark cycle (lights on at 6:30 am). Rats were given ad libitum access 
to standard laboratory rat chow pellets and tap water for the duration of the experimentation. The animals 
received humane care in accordance with the principles of the South African National Standard for the 
care and use of animals for scientific purposes (South African Bureau of Standards, SANS 10386, 2008). 
The project was approved by the Animal Research Ethics Committee of Sub-Committee B of 
Stellenbosch University (reference #10GK_HIL01). 
Experimental rats were divided into four main groups, namely: (1) control placebo (PLA);  
(2) PG-CHR, animals treated with P. glandulosa for 8 weeks prior to injury and after injury, up to the 
time of sacrifice; (3) PG-AI, animals treated with P. glandulosa after injury (first treatment, 2 h after 
injury), up to the time of sacrifice and (4) NSAID, animals treated with Voltaren Emulgel® (diclofenac) 
directly after injury, up to the time of sacrifice. All four groups were subdivided into sacrifice and data 
collection time points of t = 0 h (before injury), 1 h, 3 h, 1 day and 7 days, post-injury. Each main group 
had an n = 25, i.e., 5 rats per time point per group (total of 100 rats). 
Rats in the different experimental groups were matched for body mass at the start of the  
protocol (PLA: 456.47 ± 9.74 g; PG-CHR: 445.98 ± 11.21 g; PG-AI: 439.12 ± 14.84 g; NSAID:  
442.25 ± 12.58 g). 
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2.2. P. Glandulosa and Diclofenac Treatments 
The P. glandulosa powder consisted solely of dry-milled P. glandulosa pods [26]. To prepare 
treatment, P. glandulosa powder was weighed daily for each animal in the treatment group and set into 
a mixture of commercially available gelatine/jelly cubes of 1 mL volume. These jelly cubes were fed to 
each animal individually for 8 weeks, to ensure absolute compliance and dose control. The dosage of 
100 mg/kg/day P. glandulosa was calculated based on the daily dosage prescribed for human adults on 
this commercially available supplement. We have previously shown this dose to elicit beneficial 
metabolic changes in rats [26,27]. During the 8-week experimental period, the control animals received 
placebo jelly cubes. 
The P. glandulosa preparation was supplied by P. Schoeman, who is the patent holder of the  
P. glandulosa supplement preparation method. A voucher herbarium specimen was prepared and lodged 
at the Stellenbosch herbarium. The composition of the product was analyzed by the CSIR (SA), J. Muller 
Laboratories (Pty) Ltd. and the Central Analytical Facility of the Stellenbosch University and all three 
institutions concurred on the chemical content thereof. Addendum A contains an example of the 
chemical analysis of this proprietary drug, as analyzed by J. Muller Laboratories (Pty) Ltd. 
Diclofenac, a known NSAID, served as a positive control for the anti-inflammatory effects of 
treatment. Diclofenac sodium, in the form of Voltaren Emulgel®, was applied topically to the injured 
area on the hindlimb of the rats after different time periods post-injury. The dosage of Voltaren Emulgel® 
was calculated at 57.14 mg/kg/day, which equaled to 0.57 mg/kg Diclofenac. The dosage was calculated 
based on the daily dosage prescribed for human adults. 
2.3. Induction of Experimental Muscle Contusion Injury and Sample Collection 
The contusion injury to the rat hind-limb was produced using the mass-drop model injury first 
described by Stratton et al. (1984) [28] and optimized for our laboratory by Myburgh and colleagues 
(2012) [7]. Briefly, the technique entails dropping a 200 g weight from the height of 50 cm onto the 
medial surface of the right gastrocnemius muscle of sodium pentobarbital (40 mg/kg, intraperitoneal) 
anaesthetized rats. This contusion injury was moderately severe, did not result in bone injury or affect 
gait in the injured animals. 
For sample collection, rats were euthanized by sodium pentobarbital overdose (200 mg/kg, 
intraperitoneal) and the central section of the damaged gastrocnemius muscle harvested. The harvested 
muscle was divided into two parts, one part processed for immunohistochemistry and the other part  
snap-frozen for Western blotting analysis. 
2.4. Muscle Histology and Immunohistochemistry 
For cross-sectional histology and immunohistochemistry, muscles were fixed in 10% formal saline, 
processed and embedded in paraffin wax. Five-micrometer thick cross-sections were prepared  
(Leica RM 2125 RT microtome, Nussloch, Germany) and stained with haematoxylin and eosin (H & E) 
for qualitative histological analysis. 
Immunostaining with mouse anti-rat His48 (neutrophil; 1:200; Santa Cruz Biotechnology,  
Santa Cruz, CA, USA), goat anti-mouse F4/80 (macrophage; 1:200; Santa Cruz Biotechnology,  
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Santa Cruz, CA, USA) and rabbit anti-human desmin (1:200; Santa Cruz Biotechnology, Santa Cruz, 
CA, USA) antibodies was performed on the fully automated Leica Bond-Max Autostainer system  
(Leica Microsystems, Germany) using an onboard detection kit, which included the Bond Epitope 
Retrieval Solution, peroxide block, primary antibody, post primary reagent, Bond Wash solution and 
Bond Polymer [29,30]. DAB (3,3′-diaminobenzidine tetrahydrochloride) was used as the chromogen 
(Leica Microsystems, Germany). Appropriate positive controls were used throughout the study. 
2.5. Image Analysis 
All imaging data were obtained by analyzing two sections from each muscle sample, at each time 
point for each antibody. In the injured area, five fields of view per section were imaged using a 
microscope (Nikon ECLIPSE E400; 400x objective used), equipped with a color digital camera  
(Nikon 5.0 Mega Pixels Color Digital Camera head DS-Fi2). The images presented in this article are 
only partial images of those taken at 200× magnification. Photos were used to count positively labeled 
neutrophils, macrophages and desmin-stains. Immune cells were counted manually and expressed as the 
average number of positively labeled immune cells per field of view (350 μm2) in the injured area, using 
the NIS-Elements BR imaging software package. In order for a cell to be classified a true neutrophil and 
macrophage, it had to have multilobular nuclei or single nuclei with surrounding cytoplasm, respectively. 
2.6. Western Blotting 
Protein levels were determined by standard Western blotting technique [26]. Briefly, proteins were 
extracted from the gastrocnemius muscle tissue, equal concentration of total protein loaded and  
separated on a SDS poly-acrylamide gel and electro-transferred to ImmobilonTM-P PVDF membranes.  
Ponceau red reversible stain was used to determine transfer efficacy of proteins. The membranes were 
incubated overnight in ADAM12 primary antibody (1:5000; Abcam, England, UK). For detection, 
horseradish peroxidase coupled secondary antibody (1:4000; Amersham Life Sciences, Sandton, JHB, 
South Africa) was used. Antigen-antibody complexes were visualized using ECL detection reagent 
(Amersham Life Sciences, Sandton, JHB, South Africa) and exposed to an autoradiography film 
(Hyperfilm ECL, RPN 2103) and light emission was detected. All films were analyzed by means of 
densitometry (UN-SCAN-IT; Silk Scientific Inc., Utah, UT, USA) and normalized data expressed in 
arbitrary units (AU). In all instances the membranes were stripped, by incubating in 0.2 M NaOH and 
reblotted with antibody against β-tubulin (1:1000; Cell Signalling Technology, Beverley, MA, USA) to 
verify the uniformity of protein load across the test samples. 
2.7. Statistical Analysis 
All data are presented as mean ± standard error of the mean (SEM). Statistical significance was 
analyzed by a two-way ANOVA, followed by a Bonferroni post hoc test. p < 0.05 was considered as 
statistically significant. Statistical analysis of data was performed using GraphPad Prism version 5. 
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3. Results 
3.1. Chronic P. Glandulosa Treatment Accelerates Repair of Muscle Ultrastructure 
Qualitative microscopic analysis of the fiber architecture post-contusion injury indicated that 
irrespective of treatment, the blunt force to the muscle belly significantly damaged and disrupted the 
skeletal muscle fibers, resulting in red blood cell accumulation in the interstitial spaces at 1 h and 3 h 
after injury (Figure 1B,E,H,K). Representative pictures for 1 h after injury are not included as differences 
between 1 and 3 h post-injury cannot be easily discerned visually. Edema was present in both treated 
and untreated groups, confirmed by the widening of the interstitial spaces between the fibers at this early 
time point. Histological comparison between the placebo (PLA) and the treatment groups illustrated a 
significant influx of immune cells 1 day after injury in all four groups. However, this influx was 
relatively limited in the group chronically treated with P. glandulosa (PG-CHR), when compared to all 
other groups. The immune cells remained visible in the injured area of the PLA, post-injury treated group 
(PG-AI) and the non-steroidal anti-inflammatory treated (NSAID) groups for up to day 7 post-injury 
(Figure 1D,J,M), but were undetectable in the PG-CHR group at the same time point (Figure 1G).  
This significant reduction in infiltrating neutrophils in the chronically treated P. glandulosa group is also 
reflected in the immunohistochemistry slides (Supplementary data: Addendum B, Figure 1C,F). By day 
7 only the chronically treated P. glandulosa group (Figure 1G) displayed near normal muscle 
architecture, indicative of successful progressing muscle regeneration. 
 
Figure 1. Cont. 
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Figure 1. Ultrastructural changes over time after experimental contusion injury, stained by 
H & E. Figure (A) represent uninjured samples; Figures (B–D) represent samples taken from 
PLA animals at 3 h (B), 1 day (C) and 7 days (D) post-injury; Figures (E–G), (H–J) and 
(K–M) represent similar time points in the PG-CHR, PG-AI and NSAID groups 
respectively. Scale bar represents 100 μm; Figures (B), (E), (H) and (K) represent muscle 
fiber destruction and vascular disruption; Immune cells infiltration into the injured area is 
visible from 1 day post-injury (Figures (C), (F), (I) and (L)). Solid white arrows indicate red 
blood cells, solid black arrows points to newly regenerated muscle fibers and dashed arrows 
indicate immune cells. 
3.2. P. Glandulosa Treatment Blunted the Neutrophil Response to Contusion Injury 
Clear differences were evident between the various experimental groups with regards to neutrophil 
infiltration. No neutrophils were present in the any of the experimental groups before injury, whereas 
contusion injury resulted in a significant (between 30- and 40-fold) transient elevation in neutrophils on 
day 1 after injury, which normalised by day 7 post-injury (p < 0.0001) (Figure 2). On day 1 post-injury, 
the PG-CHR (p < 0.0001), PG-AI (p < 0.001) as well as the NSAID treatment groups (p < 0.0001) 
displayed a significantly lower number of neutrophils compared to the untreated group (PLA). 
Furthermore, the magnitude of the neutrophil response as assessed on day 1 post-injury was similar in 
these three treatments groups. 
3.3. P. Glandulosa Treatment Did Not Affect Macrophage Response to Contusion Injury 
Similar to the neutrophil data, the presence of macrophages was undetectable in the uninjured control 
samples (Figure 3). Of the time-points assessed, the peak number of macrophages (p < 0.001) present 
in the injured area, was 1 day after injury in all four experimental groups. These increased values had 
again normalised by day 7 after injury (p < 0.001). None of the treatments seem to have any effect on 
macrophage infiltration at the time points assessed. 
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Figure 2. Neutrophil (His48 stain) infiltration into injured area after contusion injury 
with/without P. glandulosa treatment. The data are expressed as mean ± SEM. Analysis was 
done by two-way ANOVA. n = 5 per time-point/per group; Differences over time are 
indicated by solid lines and broken black lines indicate group differences at specific time 
points; Significance: All groups: *** p < 0.0001 uninjured vs. 1 day; 1 h vs. 1 day; 3 h vs.  
1 day; 1 day vs. 7 days. 1 Day: *** p < 0.0001 PLA vs. PG-CHR; PLA vs. NSAID;  
** p < 0.05 PLA vs. PG-AI. 
 
Figure 3. Macrophage infiltration into injured area after contusion injury with/without  
P. glandulosa treatment. The data are expressed as mean ± SEM. Analysis was done by  
two-way ANOVA. n = 5 per time-point/per group; Differences over time are indicated by 
solid lines; Significance: All groups: **p < 0.001 uninjured vs. 1 day; 1 h vs. 1 day; 3 h vs. 
1 day; 7 days vs. 1 day. 
3.4. ADAM12 Expression is Enhanced in Response to Chronic P. Glandulosa Treatment 
According to the Western blot analysis, expression of the satellite cell proliferation marker, ADAM12, 
was significantly elevated from 3 h post-injury (p < 0.0001) and this significant elevation persisted for 
at least 24 h (p < 0.0001), with the expression again normalized to uninjured levels on day 7 after injury, 
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in all experimental groups (p < 0.0001) (Figure 4A,B). Of all three treatments assessed, the 8-week 
chronic treatment with P. glandulosa (PG-CHR) showed the most significant effect with significantly 
increased (p < 0.05) expression of ADAM12, on day 1 post-injury, when compared to the PLA group. 
Although post-injury treatment (PG-AI) seemed to suppress ADAM12 expression at 3 h, when compared 
to PLA, it was associated with a significant increase in ADAM12 expression from 3 to 1 day. NSAID 
treatment was associated with a similarly suppressed ADAM12 expression at 3 h, but with this treatment, 
the relative suppression persisted at 1 day after injury. Indeed, the NSAID group expressed lower levels 
of ADAM12, compared to the chronically treated P. glandulosa group at both 3 h and 1 day post-injury, 
significantly so on the latter (p < 0.001). For the sake of clarity the statistical differences observed 
between the different time-points in each experimental group is illustrated in Figure 4C. 
 
Figure 4. ADAM12 expression in skeletal muscle following a contusion injury. (A) 
Representative Western blots. Top 4 bands represent ADAM12 expression and the bottom 
bands represent β-tubulin expression (confirm equal loading of the protein); (B) Combined 
data for all the different groups; (C) Statistical differences observed between the different 
time-points in each experimental group. Values are expressed relative to the uninjured 
values. The data are expressed as mean ± SEM; Analysis by two-way ANOVA; n = 5  
per time-point/per group; Differences over time are indicated by solid lines and broken black 
lines indicate group differences at specific time points; Significance: *** p < 0.0001,  
** p < 0.001 and * p < 0.05. 
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3.5. Desmin Expression is Increased in Response to Chronic P. Glandulosa Treatment 
Desmin expression was found to steadily increase after injury, with highest values at the 7 days  
post-injury time point, in all four different experimental groups. At the 7-day post-injury time-point, the 
chronically treated P. glandulosa group (PG-CHR) displayed significantly elevated desmin expression 
compared to all other groups (Figure 5). While post-injury P. glandulosa-treatment had no effect on the 
expression of desmin, the NSAID-treated group displayed significantly decreased desmin expression, 
when compared to all other groups, indicative of delayed regeneration. 
 
Figure 5. Desmin expression in skeletal muscle following a contusion injury. The data are 
expressed as mean ± SEM; Analysis by two-way ANOVA; n = 5 per time-point/per group; 
Differences over time are indicated by solid black lines (PLA), solid blue lines (PG-CHR), 
solid red lines (PG-AI) and broken black lines indicate group differences at specific time 
points; Significance: *** p < 0.0001, ** p < 0.001 and * p < 0.05. 
4. Discussion 
When muscle is injured, such as during a contusion injury, chemotactic factors are released by the 
myocytes and other surrounding cells, which results in immune cell mobilization and attraction to the 
injured area [3,9,31]. In this study we focused on P. glandulosa as a possible pre- and/or post-injury 
treatment option after a contusion injury. We assessed effects on neutrophil and macrophage infiltration 
into the injured area, as well as associated consequences in the context of regeneration. 
Indeed, we present compelling evidence for an effect of P. glandulosa at tissue level in the early 
response to muscle injury. Firstly, chronic P. glandulosa treatment was found to significantly reduce 
neutrophil infiltration into the injured area, suggestive of a decreased pro-inflammatory signal and 
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probably less neutrophil-associated secondary damage. Secondly, in support of this interpretation, we 
report an associated significant increase in the expression of ADAM12 (day 1 post-injury) and desmin 
(day 7 post-injury) suggesting an enhanced regenerative process. Since direct effects on satellite cell 
recruitment and incorporation into injured fibers were not assessed, no conclusion can be made on 
potential direct effects on this cell type. However, given the recent report of other plant products that 
had effects on both inflammation and satellite cell action directly after chronic treatment [7,24], this 
possibility cannot be excluded and remains to be elucidated. The fact that post-injury treatment of  
P. glandulosa did not yield similar benefits has more than one potential explanation. Firstly, the first 
post-injury dose may have been administered too late to affect early initiation steps for inflammation. 
However, since the neutrophil response was indeed significantly inhibited, this is unlikely. Rather, the 
active substance(s) also target other, as yet unknown, cellular targets for which modulation may occur 
over a longer time-period, rather than acutely. 
The current study is the first to illustrate potential benefit for P. glandulosa in the context of muscle 
injury and inflammation. As a result, the potential mechanism(s) for the effects reported has not yet been 
extensively investigated. Neutrophil blunting effects have been reported previously, albeit with other 
natural substances [7,32–34]. From the literature, the ability of P. glandulosa to blunt neutrophil 
infiltration into the site of injury suggests that treatment either caused: (i) a lesser degree of activation 
of these immune cells; (ii) a lesser capacity for extravasation of the neutrophils; or (iii) decreased 
maturation and proliferation of neutrophils. Plant-derivatives have previously been shown to effectively 
reduce the infiltration of neutrophils into the site of injury by either reducing neutrophil extravasation 
from the blood [24], blunting neutrophil migration [24], partially inhibiting the activation of the immune  
cells [33] or inhibiting neutrophil chemotaxis [34]. A limitation of the current study was that time-points 
between 1 and 7 days post-injury were not assessed. Since macrophages usually peak around day  
5 post-injury, we may have missed macrophage responses to the treatment, which most likely occurred 
5 days after injury. Nevertheless, we show promising beneficial effects on inflammation in the  
context of neutrophils, so that more product-specific research is warranted, to enable firmer conclusions 
on mechanisms. 
Furthermore, many phytomedicines exert effects through antioxidant mechanisms. Earlier findings 
have demonstrated that neutrophil attraction, adhesion and migration can be influenced by an  
increase in ROS generation [35] and that antioxidant treatment, which scavenges ROS, would alleviate 
the excessive ROS production and decrease attraction, adhesion and migration of circulating  
neutrophils [36,37]. However, in a previous study, conducted in our laboratory (unpublished data), the 
antioxidant capacity of P. glandulosa was evaluated in terms of lipid hydroperoxides (LOOH) and 
thiobarbituric acid reactive substance (TBARS) assays and we could find nosignificant differences 
between control and treated groups. It therefore seems reasonable to assume that P. glandulosa treatment 
did not act as an antioxidant. 
In addition to the beneficial effects of the experimental product assessed, our results illustrate some 
alarming undesired effects of the NSAID, diclofenac. Similar to previous findings [38–40], NSAID 
treatment immediately after injury, resulted in the blunting of the inflammatory phase, by decreasing 
neutrophil infiltration into the injured area (Figure 2). In this context, and in the light of the rather 
inconclusive macrophage data, the natural and NSAID treatments seem similar in action. However, when 
turning to other parameters assessed, large differences become evident. 
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The level of ADAM12 expression in gastrocnemius muscles, at different time-points after injury, has 
not been measured in an in vivo model before and is a novel aspect of the current study. Our results confirm 
that previous reports of low ADAM12 expression levels in vitro differentiated muscle ﬁbers [41–43], with 
higher expression only during proliferation and very early stages of differentiation [44], can be 
extrapolated to the in vivo situation. Our data showing an increased ADAM12 response at 3 h post-injury 
is in accordance with previous research which documented that the first signs of myogenic differentiation 
occur between 3 and 8 h after injury [45]. It has been reported that myoblasts fuse to form myotubes and 
reconstruct damaged myofibers as early as 2 days after injury [46–48]. This data also coincides with our 
ADAM12 data showing significant elevation in ADAM12 expression 1 day after injury in PG-CHR, 
relative to PLA. Furthermore, in our study, at day 7 after injury, the expression of ADAM12 was reduced 
to basal levels, suggesting that most satellite cells have differentiated and fused to form differentiated 
myotubes by day 7. The histology (Figure 1) and desmin (Figure 5) data supports this interpretation.  
The fact that chronic P. glandulosa treatment increased the ADAM12 expression at early time-points 
relative to the PLA indicates that the treatment may facilitate more effective recovery by enhancing early 
proliferation. In stark contrast, the NSAID treatment resulted in significantly suppressed ADAM12 
expression (particularly at 3 h), pointing to an inhibitory effect on repair. This undesired effect was also 
evident from the desmin response. 
Desmin levels usually increase significantly during myogenesis and remain elevated in newly 
matured myofibers [49], which explains the relative late response in our protocol time course. On day 7, 
and in accordance with our other data suggesting more effective muscle fiber repair, desmin expression 
was significantly higher after chronic P. glandulosa treatment. In contrast, desmin expression was 
significantly lower than PLA after NSAID treatment, again pointing to an inhibitory effect of NSAID 
on repair, as suggested in the literature [3]. It is important to note that NSAID treatment was administered 
for up to 7 days in the current study. If NSAID administration could be limited to 1–2 days post-injury, 
it is possible that the initial suppression of repair could be overcome, while maintaining the beneficial 
effect of neutrophil blunting (and thus secondary damage) reported here. However, it is clear that NSAID 
treatment should not be administered after these very early time points post-injury. 
5. Conclusions 
Our data indicate that P. glandulosa treatment results in more effective muscle repair after sterile 
contusion injury–at least in part due to modulating effects on neutrophil infiltration–while longer term 
application of topical NSAID (diclofenac) may inhibit repair, resulting in ineffective recovery. 
The fact that P. glandulosa is categorized as an invader tree in South Africa–and probably other 
countries of export too–illustrates the ethnopharmacological significance of our novel results: this tree 
seems to be an ideal candidate for harvesting for natural medicine, as there is no imminent risk of 
depleting natural resources of the plant. The use of an economical, natural and readily available 
substance, such as the one we identified here, as treatment to limit acute inflammation and increase 
muscle regeneration, could have far-reaching implications in not only the sporting arena and health 
sectors, but also in plant and wildlife conservation. 
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